SCHEMBL3171389

SCHEMBL3171389

CC(=O)NCCNc1cc(NCCNC(=O)C=Cc2cccc([N+](=O)[O-])c2)nc(-c2ccc(Cl)cc2)n1

nearest known ligand 0.56

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 11/20 0.56
MAPT P10636 9/20 0.56
LMNA P02545 4/20 0.56
SMN1; SMN2 Q16637 3/20 0.56
MAPK1 P28482 1/20 0.56
MEN1 O00255 4/20 0.52
KMT2A Q03164 4/20 0.52
RECQL P46063 1/20 0.52
HPGD P15428 3/20 0.51
RAB9A P51151 2/20 0.51
THRB P10828 1/20 0.51
GAA P10253 2/20 0.49
PKM P14618 1/20 0.49
L3MBTL1 Q9Y468 1/20 0.49
TRPV1 Q8NER1 1/20 0.47
NPC1 O15118 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3171377 1.00 ALDH1A1 (0.56) ALDH1A1MAPTLMNASMN1; SMN2MAPK1
SCHEMBL3165800 0.92 ALDH1A1 (0.56) ALDH1A1MAPTLMNASMN1; SMN2MAPK1
SCHEMBL3165811 0.92 ALDH1A1 (0.56) ALDH1A1MAPTLMNASMN1; SMN2MAPK1
SCHEMBL3172229 0.90 ALDH1A1 (0.55) ALDH1A1MAPTLMNASMN1; SMN2MAPK1
SCHEMBL3172219 0.90 ALDH1A1 (0.55) ALDH1A1MAPTLMNASMN1; SMN2MAPK1
SCHEMBL3170642 0.86 KMT2A (0.49) ALDH1A1MAPTLMNASMN1; SMN2MEN1
SCHEMBL3170630 0.86 KMT2A (0.49) ALDH1A1MAPTLMNASMN1; SMN2MEN1
SCHEMBL3164802 0.84 L3MBTL1 (0.52) ALDH1A1MAPTLMNASMN1; SMN2MEN1
SCHEMBL3169453 0.84 CYP1A2 (0.47) ALDH1A1MAPTLMNASMN1; SMN2MAPK1
SCHEMBL3169445 0.84 CYP1A2 (0.47) ALDH1A1MAPTLMNASMN1; SMN2MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1465631-B1 PYRIMIDINE A2B SELECTIVE ANTAGONIST COMPOUNDS, THEIR SYNTHESIS AND USE OSI PHARM INC (US) 2010-02-24 EP disclosed